logo
Delhi must talk tough with Beijing over China's construction of a dam on Brahmaputra

Delhi must talk tough with Beijing over China's construction of a dam on Brahmaputra

Indian Express2 days ago
On July 19, Chinese Premier Li Qiang travelled to Nyingchi in Tibet to launch the construction of a 1.2 trillion yuan ($167.8 billion) mega hydropower project on the Yarlung Tsangpo River. This massive project is being constructed without prior consultation with lower riparian India, though its likely location in Medog County is barely 30 km from the place the river enters India and becomes the Siang, the main channel of the Brahmaputra River system. The project has several ominous implications for India, but the Government of India has not commented publicly on its construction.
While the project details have not been made public by China, except its cost and that it will involve five cascade hydropower plants, Chinese media reports suggest that it will generate nearly 300 billion kilowatt-hours (kWh) of electricity annually, more than thrice the designed capacity (88.2 billion kWh) of the Three Gorges Dam in China, currently the largest in the world. It would involve drilling four to six 20-km tunnels and diversion of half of the river's flow.
India ought to be deeply concerned about the downstream impact, which will manifest in many ways. First, a project of this magnitude will inevitably interfere with the flow of waters in the Brahmaputra. The contribution of glacier melt, snow melt and precipitation in Tibet to the waters in the Siang could range from 25 per cent to 35 per cent. There will be significant impact downstream of any diversion or pounding of water in Tibet, particularly in the lean season. The construction of five massive hydropower plants in cascade is likely to involve reservoir-like structures, even though it is claimed to be a run-of-the-river project. Altering natural river flows will harm aquatic ecosystems, fisheries, sedimentation, and biodiversity hotspots.
Second, even more worrying is the risk of flooding. While reservoirs can regulate floods, unannounced or sudden releases of water during heavy rainfall, or in a natural disaster like an earthquake, to protect the structure, can exacerbate downstream flooding, causing immense damage to life and property.
Third, this massive project involving tunnelling through fragile and young mountains is being undertaken in an area classified as Seismic Zone V (very high risk), which has seen major deep and shallow earthquakes in the past. Medog County lies within the Eastern Himalayan Syntaxis, a highly seismic region influenced by the Himalayan Frontal Thrust and local faults like the Medog Fault. Challenges such as reservoir-induced seismicity, tunnelling, geological miscalculations, and previous Chinese lapses in construction quality (for instance, in the Neelum-Jhelum project in Pakistan-Occupied Kashmir) leave zero margin for engineering error — post-construction, there will be an ever-present danger of disasters.
Fourth, China has leveraged its advantage as a predominantly upper riparian vis-à-vis its neighbours and has mostly withheld meaningful cooperation with downstream countries. For instance, China's development of a cascade of 12 smaller hydropower projects on the Mekong (called Lancang in China) has led to irregular fluctuations, drying out of areas, and depletion of fish catches and fertile sedimentation in the Lower Mekong Basin, affecting Myanmar, Thailand, Laos, Cambodia and Vietnam. This pattern of behaviour presages foreseen and unforeseen consequences of the proposed dam for India and Bangladesh.
Fifth, China's track record of cooperation under three MoUs with India over the past two decades has been unsatisfactory. China has suspended the supply of wet-season hydrographic data for the Brahmaputra and the Sutlej from time to time. It has not agreed to provide lean-season data, let alone discuss broader cooperation like the sharing of waters of trans-border rivers. Not one collaborative project has been undertaken under the umbrella MOU for cooperation signed in 2013.
Finally, neither China nor India is a signatory to the UN Convention on the Law of the Non-Navigational Uses of International Watercourses (1997). However, two key principles of the Convention, 'equitable and reasonable utilisation' of shared waters and the 'obligation not to cause significant harm' to downstream states, are a part of customary international law. India has been a responsible co-riparian state, including with Pakistan, even after the Indus Waters Treaty was put in abeyance after the Pahalgam terrorist outrage. The same cannot be said of China.
The present strategy of quiet diplomacy with China is not working. Strangely, none of our readouts on recent high-level conversations with China have even mentioned the Medog project. Looking ahead, there must be strong signalling of our deep concerns about this project to China, both through diplomatic channels and in public comments. If the roles were reversed, there is absolutely no possibility of China being similarly circumspect. It is also worthwhile recalling how forceful Pakistan has been in dealings with India as a lower riparian, even though we had given generous terms under the Indus Waters Treaty.
The scope of the dialogue with China must be expanded beyond the issue of hydrographic data. As an affected party, we have every right to insist on full visibility on the technical specifications of the project, its environmental impact studies and how China proposes to tackle the seismic challenge. We must push for transparent and broader transboundary cooperation, similar to China's engagements with Kazakhstan on rivers like the Ili and Irtysh, to protect our existing and proposed user rights and other interests as a co-riparian. Indeed, we should seek suspension of work on the project until the relevant issues have been addressed. There should be a clear message that China undertaking a massive project like this without taking on board our legitimate concerns will have consequences for bilateral relations.
We must undertake a series of activities on our own. Considering the danger of floods and reduction in lean-season flows, India has no alternative but to create storage structures to moderate the risks in the immediate downstream. India should reassess the quantum of water contributed by major tributaries and local hydrological systems using its remote sensing datasets, geospatial modelling tools and legacy hydrological data to reduce dependency on upstream data from China. We have the means and expertise to monitor the project and make the findings of those studies public.
Finally, it is important to build a sustained narrative about China's unilateral actions in the upstream and escalate the issue bilaterally as also in our broader messaging on India-China relations. Our NGOs should raise this matter in relevant international platforms.
We must appreciate that India's circumspection could be seen by China as a sign of weakness. This wouldn't help in pursuing our larger agenda of rebuilding bilateral relations with our northern neighbour.
The writer is former ambassador to China
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sacred Relics Of The Buddha Return To India After 127 Years
Sacred Relics Of The Buddha Return To India After 127 Years

NDTV

time25 minutes ago

  • NDTV

Sacred Relics Of The Buddha Return To India After 127 Years

The sacred relics of the Buddha, originally excavated from Piprahwa in present-day Uttar Pradesh in 1898, were returned to India today after 127 years. The relics were handed over to the Government of India following coordinated diplomatic and cultural efforts to stop their auction in Hong Kong. The relics recently surfaced in a Sotheby's auction listing in Hong Kong, which included gold, garnet, and crystal ornaments linked to the 1898 excavation. The Government of India launched a diplomatic initiative involving the Ministry of Culture, the Ministry of External Affairs, and Indian missions in Hong Kong and London to secure their return. The International Buddhist Confederation (IBC), an autonomous body under the Ministry of Culture, supported the effort by engaging with global Buddhist networks and building moral pressure against the sale. "The return of the Piprahwa relics is not just a matter of archaeology or heritage, it is the return of a living faith's most sacred memory. Under the leadership of Prime Minister [Narendra] Modi, India has shown how diplomacy can be rooted in dharma," said Abhijit Halder, Director General of IBC. The relics were originally discovered by British engineer William Claxton Peppe at the Piprahwa stupa near the Indo-Nepal border. The find included reliquaries, crystal caskets, ornaments, and charred human remains. An inscription on the relic casket identifies them as belonging to the Sakya clan, relatives of the Buddha. A formal reception was held in New Delhi on July 30. It was attended by Buddhist monks, diplomats, and cultural officials. The relics are currently housed at the National Museum for public viewing and academic exhibitions. They are expected to be permanently enshrined at a significant Buddhist site, such as Sarnath, Kushinagar, or the Lumbini-Kapilavastu Corridor. Professor Arvind Kumar Singh of Lumbini Buddhist University, formerly of Gautam Buddha University, wrote, "This momentous repatriation marks a watershed in India's efforts to reclaim and preserve its spiritual and cultural heritage." "This is not just a return of sacred relics, but it is the return of India's soul," he added.

China Summons Nvidia Over Alleged Security Risk in H20 AI Chips
China Summons Nvidia Over Alleged Security Risk in H20 AI Chips

Mint

time26 minutes ago

  • Mint

China Summons Nvidia Over Alleged Security Risk in H20 AI Chips

Chinese authorities summoned Nvidia Corp. representatives to discuss alleged security risks related to its H20 artificial intelligence chips. The Cyberspace Administration of China said in a statement on Thursday that the chips had a serious security vulnerability and asked Nvidia staff to explain the risks and provide relevant documents. At issue are location tracking and remote shutdown capabilities of the products, according to the statement. Nvidia, which hasn't publicly acknowledged that the H20 chips have such functions, didn't immediately respond to a request for comment outside of regular business hours. The move marked an abrupt change in tone after an apparent improvement in trade relations between the US and China, coming just days after a Stockholm summit between the two nations' trade officials. The particular H20 product, which had in April been banned from sale to China by the Trump administration, had only recently been cleared to return to the market by US authorities. Nvidia and Advanced Micro Devices Inc. said this month they would resume sales of some AI chips in China after securing Washington's assurances that such shipments would get approved. US lawmakers slammed the resumption over risks that it would boost Beijing's military capabilities and expand its ability to compete with the US in AI. Administration officials responded by saying China already had more capable products than the H20 from domestic providers like Huawei Technologies Co. The less-advanced H20 chip was designed to comply with Washington's earlier trade curbs on China. This article was generated from an automated news agency feed without modifications to text.

Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say
Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say

Time of India

time41 minutes ago

  • Time of India

Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say

AI-generated image India's pharmaceutical sector has given its insights into US President Donald Trump's announcement of a 25 per cent tariff on all Indian imports starting August 1, warning that the move could significantly disrupt American healthcare rather than weaken Indian industry. While uncertainty remains about whether pharmaceuticals will fall under the new tariff list- given Trump's April declaration that excluded essential drugs- the reaction from Indian pharma stakeholders has been swift and pointed. 'He is trying to kill the market of the Indian economy, but it is not going to happen,' said Dilip Kumar, Chairman of the Chamber of Commerce's Medical Tourism wing, speaking to ANI. 'We are exporters, especially of medical equipment, pharmaceuticals, and disposables, which mostly come from India. The American market is dependent upon Indian and Chinese markets," he added. Kumar also said that, 'India won't be impacted, as we will go by the route of exporting to European countries. We can survive in the toughest times and bounce back." Also read: 25% tariff on India; 'dead economies' jibe, trade deal with Pakistan & more – Key points Echoing these sentiments, Pharmaceuticals Export Promotion Council of India (Pharmexcil) Chairman Namit Joshi issued a statement through PTI highlighting India's indispensable role in the US drug supply chain. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo 'India has long been a cornerstone of the global supply chain for affordable, high-quality medicines, particularly in the generic drug market, where it supplies nearly 47 per cent of the pharmaceutical needs of the US,' said Joshi. 'Indian pharmaceutical companies play a vital role in ensuring the affordability and availability of essential medications, including life-saving oncology drugs, antibiotics, and chronic disease treatments,' he added. Joshi warned that the immediate fallout of the tariff move would be rising drug prices and possible shortages in the US. 'Any disruption to this supply chain will inevitably lead to shortages and escalating prices, ultimately harming US consumers and healthcare systems.' He noted that while the short-term impact would be painful, the long-term risks were even more serious. 'The long-term impact will be even more severe. The US market, heavily reliant on India for Active Pharmaceutical Ingredients (APIs) and low-cost generics, faces a daunting challenge in finding alternative sources that can match the scale, quality, and affordability that India offers," Joshi said continuing his insights. Efforts to transition manufacturing and API production to other countries or domestic facilities in the US could take 'at least 3–5 years before meaningful capacity can be established,' he cautioned. Despite the uncertainty, Pharmexcil said it remained committed to working with stakeholders to maintain India's role as a reliable supplier of affordable medicines. 'We continue to engage with policymakers to emphasise the importance of affordable access to medicines and the indispensable role Indian pharmaceutical companies play in meeting the growing global demand for essential drugs,' Joshi said. Stay informed with the latest business news, updates on bank holidays and public holidays . Discover stories of India's leading eco-innovators at Ecopreneur Honours 2025

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store